Polymeric Matrix System for Prolonged Delivery of Tramadol Hydrochloride, Part II: Biological Evaluation

被引:21
作者
Ammar, Hussein O. [1 ]
Ghorab, Mahmoud [2 ]
El-Nahhas, Soheir A. [1 ]
Kamel, Rabab [1 ]
机构
[1] Natl Res Ctr, Dept Pharmaceut Technol, Cairo, Egypt
[2] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt
关键词
analgesia; bioadhesion; pain; tramadol hydrochloride; transdermal; DRUG-DELIVERY; PAIN; FILMS; FORMULATION; MANAGEMENT; SAFETY; SKIN;
D O I
10.1208/s12249-009-9294-2
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
This study is an extrapolation of our previous one (part I) concerned with the formulation and physicochemical evaluation of a novel, simple, monolayer, easy-to-use, cost-effective, and aesthetically acceptable bioadhesive transdermal patch for tramadol hydrochloride. The current work is focused on bioadhesion, skin tolerability, and pharmacodynamic evaluation. Using naked rat skin, chitosan-EudragitA (R) NE30D (1:1) film attained best bioadhesive properties. During in vivo studies, it also showed a significantly extended analgesic effect compared to both oral formula and chitosan single polymeric film using the hot plate test method. All the polymeric films were skin tolerable for the intended period of application according to the Draize test. The success of our approach can proudly, positively contribute into the world of pain management and arguably push transdermal delivery to realize its great promise.
引用
收藏
页码:1065 / 1070
页数:6
相关论文
共 27 条
[1]
Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery [J].
Akhgari, A. ;
Farahmand, F. ;
Garekani, H. Afrasiabi ;
Sadeghi, F. ;
Vandamme, T. F. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (04) :307-314
[2]
Extended-release tramadol (ULTRAM®ER):: A pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain [J].
Barkin, Robert L. .
AMERICAN JOURNAL OF THERAPEUTICS, 2008, 15 (02) :157-166
[3]
Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery [J].
Cafaggi, S ;
Leardi, R ;
Parodi, B ;
Caviglioli, G ;
Russo, E ;
Bignardi, G .
JOURNAL OF CONTROLLED RELEASE, 2005, 102 (01) :159-169
[4]
Chickering D.E., 1999, BIOADHESIVE DRUG DEL
[5]
Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
[6]
Development of opioid formulations with limited diversion and abuse potential [J].
Fudala, PJ ;
Johnson, RE .
DRUG AND ALCOHOL DEPENDENCE, 2006, 83 :S40-S47
[7]
Recent advances in the pharmacological management of pain [J].
Guindon, Josee ;
Walczak, Jean-Sebastien ;
Beaulieu, Pierre .
DRUGS, 2007, 67 (15) :2121-2133
[8]
Mu opioid receptor-dependent and independent components in effects of tramadol [J].
Ide, Soichiro ;
Minami, Masabumi ;
Ishihara, Kumatoshi ;
Uhl, George R. ;
Sora, Ichiro ;
Ikeda, Kazutaka .
NEUROPHARMACOLOGY, 2006, 51 (03) :651-658
[9]
Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain [J].
Malonne, H ;
Coffiner, M ;
Fontaine, D ;
Sonet, B ;
Sereno, A ;
Peretz, A ;
Vanderbist, F .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (02) :113-120
[10]
Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions [J].
McCarron, PA ;
Donnelly, RR ;
Zawislak, A ;
Woolfson, AD .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (2-3) :268-279